ORGS
Orgenesis (ORGS)
$
98About Orgenesis (ORGS)
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Details
Daily high
$3.98
Daily low
$3.81
Price at open
$3.76
52 Week High
$10.80
52 Week Low
$2.50
Market cap
19.0M
Dividend yield
0.00%
Volume
18,087
Avg. volume
26,715
P/E ratio
-.46
Orgenesis News
Details
Daily high
$3.98
Daily low
$3.81
Price at open
$3.76
52 Week High
$10.80
52 Week Low
$2.50
Market cap
19.0M
Dividend yield
0.00%
Volume
18,087
Avg. volume
26,715
P/E ratio
-.46